Calcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammation.
Infection and inflammation are common complications that seriously affect the functionality and longevity of implanted medical implants. Systemic administration of antibiotics and anti-inflammatory drugs often cannot achieve sufficient local concentration to be effective, and elicits serious side ef...
Main Authors: | Zhiling Zhang, Camilla A Nix, Utku K Ercan, Jonathan A Gerstenhaber, Suresh G Joshi, Yinghui Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3883660?pdf=render |
Similar Items
-
Comparison of efficacy of conventional nonmodified-release minocycline and newer extended-release minocycline in treatment of acne vulgaris
by: Vidyadhar R Sardesai, et al.
Published: (2018-01-01) -
Development and assessment of minocycline sustained release capsule formulations
by: Sachikonye, Tinotenda Chipo Victoria
Published: (2010) -
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation
by: Katharina Maier, et al.
Published: (2007-03-01) -
The impact of serum protein binding on bacterial killing of minocycline
by: Li-Xia Xie, et al.
Published: (2020-06-01) -
Preparation and release characteristics study on the novel minocycline hydrochloride sustained-release capsule
by: Songfeng Zhao, et al.
Published: (2016-02-01)